enzastaurin has been researched along with Diarrhea in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, Y; Boye, M; Day, JM; Duvic, M; Hamid, O; Kim, YH; Kuzel, TM; Lin, B; Mark, LA; Musiek, A; Pinter-Brown, L; Porcu, P; Querfeld, C; Rook, AH; Rosen, ST | 1 |
Cleverly, AL; Darstein, C; Flanagan, SD; Musib, LC; Sinha, VP; Welch, PA | 1 |
2 trial(s) available for enzastaurin and Diarrhea
Article | Year |
---|---|
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Diarrhea; Drug Resistance, Neoplasm; Fatigue; Female; Humans; Hyperkalemia; Indoles; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Recurrence; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 2011 |
Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-beta inhibitor, in healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Half-Life; Headache; Humans; Indoles; Male; Middle Aged; Nausea; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Sleep | 2007 |